MACHOVÁ POLÁKOVÁ, Kateřina, Sylvie NÁDVORNÍKOVÁ, Karla ZEMANOVÁ, Hana KLAMOVÁ, Tomáš JURČEK, Dana DVOŘÁKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Marek TRNĚNÝ a Jana MORAVCOVÁ. Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders. In 52nd annual meeting ASH in Blood. 2010. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{917157, author = {Machová Poláková, Kateřina and Nádvorníková, Sylvie and Zemanová, Karla and Klamová, Hana and Jurček, Tomáš and Dvořáková, Dana and Žáčková, Daniela and Mayer, Jiří and Trněný, Marek and Moravcová, Jana}, booktitle = {52nd annual meeting ASH in Blood}, language = {eng}, title = {Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders.}, year = {2010} }
TY - CONF ID - 917157 AU - Machová Poláková, Kateřina - Nádvorníková, Sylvie - Zemanová, Karla - Klamová, Hana - Jurček, Tomáš - Dvořáková, Dana - Žáčková, Daniela - Mayer, Jiří - Trněný, Marek - Moravcová, Jana PY - 2010 TI - Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1% (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders. ER -
MACHOVÁ POLÁKOVÁ, Kateřina, Sylvie NÁDVORNÍKOVÁ, Karla ZEMANOVÁ, Hana KLAMOVÁ, Tomáš JURČEK, Dana DVOŘÁKOVÁ, Daniela ŽÁČKOVÁ, Jiří MAYER, Marek TRNĚNÝ a Jana MORAVCOVÁ. Minimal residual resistance in CML: Stable BCR-ABL gene expression at levels 0.01-0.1\%{} (IS) in the consecutive samples may be associated with BCR-ABL mutation development and MMoR lost in a small number of tyrosine kinase inhibitor responders. In \textit{52nd annual meeting ASH in Blood}. 2010.
|